Endo International Financial Statements (ENDP)
|
|
Report date
|
|
|
06.08.2021 |
05.11.2021 |
01.03.2022 |
06.05.2022 |
09.08.2022 |
|
09.08.2022 |
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
713.8 |
772.0 |
789.4 |
652.3 |
569.1 |
|
2 783 |
Operating Income, bln rub |
|
|
183.1 |
213.5 |
-404.1 |
61.3 |
-1 734 |
|
-1 863 |
EBITDA, bln rub |
? |
|
256.5 |
180.1 |
-297.4 |
167.6 |
-1 881 |
|
-1 831 |
Net profit, bln rub |
? |
|
-15.5 |
-77.2 |
-556.7 |
-65.3 |
-1 885 |
|
-2 585 |
|
OCF, bln rub |
? |
|
155.0 |
62.1 |
-49.9 |
201.3 |
|
|
213.6 |
CAPEX, bln rub |
? |
|
27.1 |
25.2 |
8.95 |
47.5 |
|
|
81.6 |
FCF, bln rub |
? |
|
127.9 |
36.9 |
-58.8 |
153.8 |
|
|
131.9 |
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
|
|
0.000 |
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
OPEX, bln rub |
|
|
212.3 |
272.5 |
308.6 |
263.3 |
210.6 |
|
1 055 |
Cost of production, bln rub |
|
|
318.5 |
286.1 |
311.2 |
273.2 |
263.8 |
|
1 134 |
R&D, bln rub |
|
|
34.7 |
25.6 |
58.5 |
36.1 |
29.8 |
|
150.1 |
Interest expenses, bln rub |
|
|
141.6 |
143.0 |
143.5 |
135.1 |
139.8 |
|
561.4 |
|
Assets, bln rub |
|
|
9 206 |
9 247 |
8 767 |
8 447 |
6 362 |
|
6 362 |
Net Assets, bln rub |
? |
|
-617.0 |
-690.3 |
-1 244 |
-1 311 |
-2 899 |
|
-2 899 |
Debt, bln rub |
|
|
8 321 |
8 320 |
8 082 |
8 110 |
8 105 |
|
8 105 |
Cash, bln rub |
|
|
1 545 |
1 569 |
1 507 |
1 413 |
1 192 |
|
1 192 |
Net debt, bln rub |
|
|
6 776 |
6 752 |
6 575 |
6 697 |
6 914 |
|
6 914 |
|
Ordinary share price, rub |
|
|
4.68 |
3.24 |
3.76 |
2.31 |
0.466 |
|
0.100 |
Number of ordinary shares, mln |
|
|
233.3 |
233.6 |
233.7 |
233.9 |
235.1 |
|
235.1 |
|
Market cap, bln rub |
|
|
1 092 |
757 |
879 |
540 |
109 |
|
24 |
EV, bln rub |
? |
|
7 868 |
7 509 |
7 453 |
7 237 |
7 023 |
|
6 937 |
Book value, bln rub |
|
|
-6 726 |
-6 705 |
-6 804 |
-6 761 |
-6 481 |
|
-6 481 |
|
EPS, rub |
? |
|
-0.07 |
-0.33 |
-2.38 |
-0.28 |
-8.02 |
|
-11.0 |
FCF/share, rub |
|
|
0.55 |
0.16 |
-0.25 |
0.66 |
0.00 |
|
0.56 |
BV/share, rub |
|
|
-28.8 |
-28.7 |
-29.1 |
-28.9 |
-27.6 |
|
-27.6 |
|
EBITDA margin, % |
? |
|
35.9% |
23.3% |
-37.7% |
25.7% |
-330.5% |
|
-65.8% |
Net margin, % |
? |
|
-2.17% |
-10.0% |
-70.5% |
-10.0% |
-331.3% |
|
-92.9% |
FCF yield, % |
? |
|
-27.4% |
-22.1% |
37.9% |
48.1% |
120.5% |
|
561.0% |
ROE, % |
? |
|
-11.3% |
-9.87% |
48.9% |
54.5% |
89.2% |
|
89.2% |
ROA, % |
? |
|
0.75% |
0.74% |
-6.93% |
-8.46% |
-40.6% |
|
-40.6% |
|
P/E |
? |
|
15.7 |
11.1 |
-1.45 |
-0.76 |
-0.04 |
|
-0.01 |
P/FCF |
|
|
-3.64 |
-4.53 |
2.64 |
2.08 |
0.83 |
|
0.18 |
P/S |
? |
|
0.39 |
0.26 |
0.29 |
0.18 |
0.04 |
|
0.01 |
P/BV |
? |
|
-0.16 |
-0.11 |
-0.13 |
-0.08 |
-0.02 |
|
0.00 |
EV/EBITDA |
? |
|
8.06 |
7.78 |
17.2 |
23.6 |
-3.84 |
|
-3.79 |
Debt/EBITDA |
|
|
6.94 |
7.00 |
15.1 |
21.8 |
-3.78 |
|
-3.78 |
|
R&D/CAPEX, % |
|
|
127.9% |
101.8% |
654.3% |
76.0% |
|
|
183.8% |
|
CAPEX/Revenue, % |
|
|
3.80% |
3.26% |
1.13% |
7.29% |
0.00% |
|
2.93% |
|
Endo International shareholders |